Evaluation of LIH383 as a new neuro-pharmacological modulator

Pain-relaying receptors represent valuable targets for the pharmaceutical industry but classical drug therapies often lead to tolerance, dependence and depression. We recently identified a new pain-related receptor and, in parallel developed, a modulator of this receptor with unique properties. These two findings promise a valuable alternative for the treatment of chronic pain and depressive disorders with possibly reduced side effects.